Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Titel:
Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Auteur:
Michel, Loren Ley, Jessica Wildes, Tanya M. Schaffer, AndrĂ¡s Robinson, Anthony Chun, Se-Eun Lee, Wooin Lewis Jr., James Trinkaus, Kathryn Adkins, Douglas